arrow
S

Susanna M. Hofmann

helmholtz zentrum munich
H指数:41
被引数:8,970

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Endothelial cannabinoid CB1 receptor deficiency reduces shear stress-induced arterial inflammation and lipid uptake

内皮大麻素CB1受体缺陷可降低剪切应力诱导的动脉炎症和脂质摄取

2026-07-070
OAAI
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease( vol 22 , 217 , 2023)

在心脏代谢疾病的临床前小鼠模型中,GIP受体激动作用可改善血脂异常和动脉粥样硬化,而与体重减轻无关 (第22卷,217,2023)

2024-09-120
OAAI
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice

LEPR细胞中GIPR的丢失会损害GIP和GIP的葡萄糖控制: GLP-1共同激动而不影响小鼠的体重和食物摄入量

2024-05-012
OAAI
Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice
2023-11-0921
OA
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease

在心脏代谢疾病的临床前小鼠模型中,GIP受体激动可独立于体重减轻而改善血脂异常和动脉粥样硬化

2023-08-176
OAAI
Fasting-sensitive SUMO-switch on Prox1 controls hepatic cholesterol metabolism
2023-08-105
OA
Non-invasive multispectral optoacoustic tomography resolves intrahepatic lipids in patients with hepatic steatosis

非侵入性多光谱光声断层扫描可解决肝脂肪变性患者的肝内脂质

2023-02-0115
OAAI
Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome
2022-12-014
OAAI
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice

GLP-1-mediated递送tesaglitazar改善雄性小鼠的肥胖和葡萄糖代谢

2022-08-2216
OAAI